NeuroSense Therapeutics Announces Pricing of $12 Million Initial Public Offering

NeuroSense announced the pricing of its initial public offering of 2,000,000 units, each consisting of one ordinary share and a warrant representing the right to purchase one ordinary share with an exercise price of $6.00 per share, at an initial public offering price of $6.00 per unit, for gross proceeds of $12 million.


Join Our Newsletter

Skip to content